Leidos Biomedical Research, Inc. is the operations and technical support contractor for the Frederick National Laboratory for Cancer Research, one of about 40 federal national laboratories and the only one focused exclusively on biomedical research. The Frederick National Lab excels at innovation and flexibility of operations, offering scientific depth, cutting-edge technologies, and enabling infrastructure.
In operating the national lab, Leidos Biomed conducts investigator-initiated, hypothesis-driven research and maintains an integrated suite of advanced technologies backed by scientific expertise in genetics, genomics, protein science, proteomics, bioinformatics, high-performance biomedical computing, laboratory animal sciences, and clinical operations. Leidos Biomed operates the Nanotechnology Characterization Laboratory in partnership with the U.S. Food and Drug Administration and the National Institutes of Standards and Technology that is pioneering medical applications of nanotechnology to fight cancer, AIDS and other diseases.
- No members are assigned.